Dr. Aragon-Ching is a specialty Oncology care physician board-certified in medical oncology, hematology, and internal medicine. She joined Inova Medical Group with more than 15 years of clinical experience. She has a special interest in the management of genitourinary (GU) cancers (prostate, bladder, kidney and testicular cancers).
Prior to joining Inova Medical Group, Dr. Aragon-Ching served as an associate professor of medicine at the George Washington University School of Medicine and Health Sciences and has a clinical focus in the treatment and research of GU cancers at the George Washington University Medical Center, where she served in varying capacities as a principal investigator of various trials on drug treatment and biomarkers. She is a well-published author, educator, and serves on the Editorial Board of various academic journals. She has been recognized as a "Top Doctor" by the Washingtonian since 2014.
Dr. Aragon-Ching serves as the clinical program director of Genitourinary Cancers within the Inova Schar Cancer Institute. In this capacity, she is excited to bring together the multidisciplinary program of excellence in clinical care and research for patients with GU malignancies.